Agilent Technologies is a global life sciences and diagnostics company that offers a range of analytical technologies, laboratory solutions, and specialised contract development and manufacturing services for the pharmaceutical and biotechnology industries. Through its CDMO platform, Agilent supports customers across the full drug development lifecycle, from discovery and process development through to clinical and commercial manufacturing.

Agilent’s CDMO capabilities are delivered through integrated operations in North America, including its BIOVECTRA business in Canada and nucleic acid solutions facilities in the United States. These capabilities provide scalable, customised manufacturing solutions for complex therapeutics and advanced modalities. The platform enables pharmaceutical and biotech companies to work with a single partner to accelerate development timelines while maintaining compliance with pharmaceutical Good Manufacturing Practices (GMP).

The company’s CDMO offering focuses on specialised and technically complex modalities such as oligonucleotides, highly potent active pharmaceutical ingredients, microbial fermentation products, and other advanced therapeutic molecules. By combining manufacturing expertise with analytical technologies and laboratory services, Agilent supports drug developers from early-stage research through clinical and commercial production.

Key products and services

Contract development and manufacturing (CDMO)

• Oligonucleotide development and manufacturing
• Microbial fermentation for biologics and therapeutic molecules
• Synthetic and complex chemistry services
• Manufacturing of highly potent active pharmaceutical ingredients (HPAPIs)

Advanced therapeutic manufacturing

• Bioreagents and specialised biomolecules
• Nucleic acid–based therapeutics manufacturing
• Cell line development and process optimisation

Process development and scale-up

• Process optimisation and technology transfer
• Analytical development and characterisation
• Scale-up from laboratory to commercial production

Clinical and commercial manufacturing

• GMP manufacturing for pharmaceutical ingredients
• Production of therapeutic molecules for clinical trials and commercial supply

Through its integrated CDMO platform, Agilent Technologies provides pharmaceutical and biotechnology companies with specialised manufacturing capabilities for advanced therapeutic modalities. By combining development expertise, analytical technologies, and GMP manufacturing infrastructure, the company supports drug developers in accelerating the translation of scientific discoveries into clinical and commercial therapies.